Biotricity Inc   (BTCY)
Other Ticker:  
Price: $1.3500 $-0.13 -8.784%
Day's High: $1.48 Week Perf: 0.75 %
Day's Low: $ 1.35 30 Day Perf: -12.34 %
Volume (M): 105 52 Wk High: $ 3.78
Volume (M$): $ 142 52 Wk Avg: $1.41
Open: $1.48 52 Wk Low: $0.48

 Market Capitalization (Millions $) 12
 Shares Outstanding (Millions) 9
 Employees -
 Revenues (TTM) (Millions $) 11
 Net Income (TTM) (Millions $) -15
 Cash Flow (TTM) (Millions $) -3
 Capital Exp. (TTM) (Millions $) 0

Biotricity Inc
Biotricity Inc is a medical technology company specializing in the development of remote monitoring solutions for chronic diseases. The company focuses on creating innovative wearable devices that collect and analyze biometric data to provide real-time insights into patient health. Biotricity's products aim to improve patient outcomes and reduce healthcare costs by enabling early detection and intervention for chronic conditions such as cardiac arrhythmias and diabetes. Through their advanced technology, Biotricity Inc aims to revolutionize the way healthcare is delivered, making it more personalized, convenient, and efficient.

   Company Address: 203 Redwood Shores Parkway Redwood City 94065 CA
   Company Phone Number: 590 4155   Stock Exchange / Ticker: NASDAQ BTCY


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Biotricity Inc

Biotricity Inc Showcases Impressive 41.859% Revenue Surge in Q2 2023, Outperforms Competitors in Medical Equipment & Supplies Industry

Biotricity Inc recently released its financial results for the April to June 30, 2023 period, showcasing significant improvements in various key performance indicators. The company's revenue surged by a staggering 41.859% compared to the corresponding quarter a year ago, while the loss per share decreased, indicating progress in its financial position. Furthermore, Biotricity Inc's growth outperformed its competitors in the Medical Equipment & Supplies industry during this time frame. Let's analyze these results in detail.
1. Strong Revenue Growth:
Biotricity Inc's revenue for the April to June 30, 2023 period reached $2.92 million, representing a robust increase of 41.859% from $2.06 million in the same quarter a year ago. Additionally, the sequential revenue growth stood at 6.355%, rising from $2.74 million in the previous quarter. This noteworthy performance indicates that Biotricity Inc has surpassed its industry peers, who achieved a 3.96% revenue improvement in the same period.

Biotricity Inc

Remarkable Q4 Revenue Surge of 27.63% Reflects Unfulfilled Profitability for Biotricity Inc. in Fiscal 2023

Biotricity Inc, a leading player in the medical equipment and supplies industry, recently announced its financial results for the period between January and March 31, 2023. The company reported a surge in revenue, showcasing a remarkable growth of 27.63% to $2.74 million compared to the same period last year.
Although the company reported a loss of $-0.09 per share, it is important to note that this loss was significantly lower than the loss per share in the previous fiscal year, representing a positive trend in the company's financial performance. Additionally, the company's revenue also showed sequential growth, advancing 11.518% from $2.46 million.
Perhaps one of the most noteworthy aspects of Biotricity Inc's financial results is the significant improvement in its net loss. In the period between January and March 31, 2023, the company reported a net loss of $-4.672 million, compared to a deficit of $-5.612 million in the corresponding period a year ago. This demonstrates the effectiveness of the company's cost-cutting measures and highlights its dedication to improving its financial standing.


Biotricity Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com